- 全部删除
您的购物车当前为空
ER-50891是一种强效的视黄酸受体α(RARα)拮抗剂。ER-50891能减少全价视黄酸的抑制作用并恢复骨形态生成蛋白2诱导的成骨细胞分化。

ER-50891是一种强效的视黄酸受体α(RARα)拮抗剂。ER-50891能减少全价视黄酸的抑制作用并恢复骨形态生成蛋白2诱导的成骨细胞分化。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,490 | In stock | |
| 5 mg | ¥ 3,980 | In stock | |
| 10 mg | ¥ 5,670 | In stock | |
| 25 mg | ¥ 8,460 | In stock | |
| 50 mg | ¥ 11,300 | In stock | |
| 100 mg | ¥ 15,300 | In stock | |
| 200 mg | ¥ 19,800 | In stock |
ER 50891 相关产品
| 产品描述 | ER-50891 is a potent retinoic acid receptor alpha (RARα) antagonist. er-50891 reduces the inhibitory effect of allosteric retinoic acid and restores osteoblast differentiation induced by bone morphogenetic protein 2. |
| 体外活性 | ER-50891显著拮抗ATRA的抑制作用,增强了前成骨细胞的总细胞代谢活性和增殖。剂量依赖性实验表明,ER-50891还能在有或没有BMP诱导的情况下,挽救ATRA抑制的OCN表达和矿化作用。ER-50891也抑制了由BMP和ATRA协同增强的ALP活性。不论是ATRA、ER-50891或它们的组合,均未显著影响BMP诱导的磷酸化Smad1/5水平。RARα的拮抗剂ER-50891能显著减轻ATRA对BMP 2诱导的成骨细胞生成的抑制效应。[3] |
| 分子量 | 432.51 |
| 分子式 | C29H24N2O2 |
| CAS No. | 187400-85-7 |
| Smiles | C(C)(C)C=1C2=C(C(=CC(=N2)C=3NC(=CC3)C4=CC=C(C(O)=O)C=C4)C5=CC=CC=C5)C=CC1 |
| 密度 | 1.223 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 10 mg/mL (23.12 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容